A new chiral hemicryptophane cage combining an electron-rich cyclotriveratrylene (CTV) unit and polar amine functions has been synthesized. The resolution of the racemic mixture has been performed by chiral HPLC, and the assignment of the absolute configuration of the two enantiomers has been achieved using ECD spectroscopy. In contrast with other hemicryptophane receptors, the two enantiomeric hosts display both remarkable enantioselectivities in the recognition of carbohydrates and good binding constants. Moreover, by switching the chirality of the CTV unit from M to P, a strong preference shift from glucose to mannose derivatives is observed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.joc.8b00276 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?
J Contemp Brachytherapy
October 2024
Fonaments Clinics Department, Universitat de Barcelona, Barcelona, Spain.
Purpose: Currently, there are many schedules for exclusive vaginal cuff brachytherapy (VCB). In 3D treatment planning for VCB dosimetry, parameters have not been analyzed. The aim of this study was to compare the most common schedules using dose-volume histogram metrics.
View Article and Find Full Text PDFEnhanced Cross-stage-attention U-Net for esophageal target volume segmentation.
BMC Med Imaging
December 2024
Laboratory of Image Science and Technology, Key Laboratory of New Generation Artificial Intelligence Technology and Its Interdisciplinary Applications, Ministry of Education, Southeast University, Sipailou 2, Nanjing, P.R. China.
Purpose: The segmentation of target volume and organs at risk (OAR) was a significant part of radiotherapy. Specifically, determining the location and scale of the esophagus in simulated computed tomography images was difficult and time-consuming primarily due to its complex structure and low contrast with the surrounding tissues. In this study, an Enhanced Cross-stage-attention U-Net was proposed to solve the segmentation problem for the esophageal gross tumor volume (GTV) and clinical tumor volume (CTV) in CT images.
View Article and Find Full Text PDFEvaluating the dosimetric impact of deep-learning-based auto-segmentation in prostate cancer radiotherapy: Insights into real-world clinical implementation and inter-observer variability.
J Appl Clin Med Phys
December 2024
Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Article Synopsis
- The study assessed the effectiveness of deep-learning-based auto-contouring in delineating clinical target volumes (CTV) and organs at risk (OARs) for prostate cancer radiotherapy, comparing it to traditional manual methods.
- It involved analyzing 28 planning CT volumes with three contour types: original, auto-segmented, and expert-defined, examining dosimetric characteristics through various metrics like dose-volume histograms and homogeneity indices.
- Results showed automated contours had smaller geometric differences from manual contours than variations between different experts, and the automated process also significantly reduced contouring time while maintaining comparable dosimetric accuracy.
Evaluation and comparison of synthetic computed tomography algorithms with 3T MRI for prostate radiotherapy: AI-based versus bulk density method.
J Appl Clin Med Phys
November 2024
Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.
Article Synopsis
- The study evaluates two synthetic computed tomography (sCT) algorithms—bulk-density-method (BM) and artificial intelligence (AI)—for generating CT images from MRI data in prostate radiotherapy.
- It involved 44 patients who underwent both MRI and treatment planning CT (TPCT), with the sCT images analyzed for their accuracy in dose coverage and alignment accuracy compared to TPCT.
- Results indicated that while AI-sCT had slightly better dose coverage and alignment accuracy, both methods performed similarly in clinical relevance, with differences in dose coverage and gamma-analysis passing rates being insignificant overall.
Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer.
Curr Oncol
November 2024
Medicine and Surgery Department, University of Milan Bicocca, 20126 Milano, Italy.
We aimed to evaluate whether progression-directed radiation therapy (PDRT) can prolong the initiation of a subsequent systemic therapy regimen in a cohort of patients with oligoprogressive NSCLC. A retrospective analysis was conducted on NSCLC patients who underwent PDRT for extracranial oligoprogressive NSCLC, defined as limited (up to five) progressing lesions following initial complete, partial, or stable response to systemic therapy according to REC1ST 1.1 and/or PERCIST 1.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!